Literature DB >> 16284014

The rise in health care spending and what to do about it.

Kenneth E Thorpe1.   

Abstract

Reforms for slowing the growth in health care spending and increasing the value of care have largely focused on insurance-based solutions. Consumer-driven health care represents the most recent example of this approach. However, much of the growth in health care spending over the past twenty years is linked to modifiable population risk factors such as obesity and stress. Rising disease prevalence and new medical treatments account for nearly two-thirds of the rise in spending. To be effective, reforms should focus on health promotion, public health interventions, and the cost-effective use of medical care.

Entities:  

Mesh:

Year:  2005        PMID: 16284014     DOI: 10.1377/hlthaff.24.6.1436

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  26 in total

1.  Analyzing national health reform strategies with a dynamic simulation model.

Authors:  Bobby Milstein; Jack Homer; Gary Hirsch
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

2.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Aggregation and the measurement of health care costs.

Authors:  Thomas E Getzen
Journal:  Health Serv Res       Date:  2006-10       Impact factor: 3.402

4.  Public health "malpractice" and the obesity epidemic.

Authors:  Kevin W Ryan; Paula Card-Higginson; Jennifer L Shaw; Sarah A Ganahl; Joseph W Thompson
Journal:  Public Health Rep       Date:  2007 May-Jun       Impact factor: 2.792

5.  Healthcare provider smoking cessation advice among US worker groups.

Authors:  David J Lee; Lora E Fleming; Kathryn E McCollister; Alberto J Caban; Kristopher L Arheart; William G LeBlanc; Katherine Chung-Bridges; Sharon L Christ; Noella Dietz; John D Clark
Journal:  Tob Control       Date:  2007-10       Impact factor: 7.552

6.  Appropriateness of laboratory testing in inflammatory bowel disease inpatients: an opportunity to reduce unnecessary healthcare costs.

Authors:  Aoibhlinn O'Toole; Gavin C Harewood
Journal:  Dig Dis Sci       Date:  2013-10-26       Impact factor: 3.199

7.  Responsive consumerism: empowerment in markets for health plans.

Authors:  Brian Elbel; Mark Schlesinger
Journal:  Milbank Q       Date:  2009-09       Impact factor: 4.911

Review 8.  Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013.

Authors:  Gordon O Matheson; Martin Klügl; Lars Engebretsen; Fredrik Bendiksen; Steven N Blair; Mats Börjesson; Richard Budgett; Wayne Derman; Uğur Erdener; John P A Ioannidis; Karim M Khan; Rodrigo Martinez; Willem van Mechelen; Margo Mountjoy; Robert E Sallis; Martin Schwellnus; Rebecca Shultz; Torbjørn Soligard; Kathrin Steffen; Carl Johan Sundberg; Richard Weiler; Arne Ljungqvist
Journal:  Sports Med       Date:  2013-11       Impact factor: 11.136

9.  Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.

Authors:  Joris Komen; Tomas Forslund; Paul Hjemdahl; Morten Andersen; Björn Wettermark
Journal:  Br J Clin Pharmacol       Date:  2016-11-30       Impact factor: 4.335

10.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.